BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27484789)

  • 1. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy.
    Ehman EC; Umetsu SE; Ohliger MA; Fidelman N; Ferrell LD; Yeh BM; Yee J; Hope TA
    Abdom Radiol (NY); 2016 Nov; 41(11):2161-2168. PubMed ID: 27484789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.
    Ehman EC; Behr SC; Umetsu SE; Fidelman N; Yeh BM; Ferrell LD; Hope TA
    Abdom Radiol (NY); 2016 May; 41(5):963-9. PubMed ID: 27193793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Washout of hepatocellular carcinoma on portal venous phase of multidetector computed tomography in a pre-transplant population.
    Kitzing YX; Ng BH; Kitzing B; Waugh R; Kench JG; Strasser SI; McCormack S
    J Med Imaging Radiat Oncol; 2015 Dec; 59(6):673-80. PubMed ID: 26238948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.
    Park S; Joo I; Lee DH; Bae JS; Yoo J; Kim SW; Lee JM
    Radiology; 2020 Sep; 296(3):554-561. PubMed ID: 32692297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic spiral computed tomography for detection of hepatocellular carcinoma before resection or orthotopic liver transplantation.
    Lopez Hänninen E; Vogl TJ; Bechstein WO; Guckelberger O; Neuhaus P; Lobeck H; Felix R
    Invest Radiol; 1998 Apr; 33(4):216-21. PubMed ID: 9556746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
    Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW
    Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT.
    Mendiratta-Lala M; Park H; Kolicaj N; Mendiratta V; Bassi D
    Abdom Radiol (NY); 2017 Jan; 42(1):171-178. PubMed ID: 27590067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features.
    Chernyak V; Flusberg M; Law A; Kobi M; Paroder V; Rozenblit AM
    J Comput Assist Tomogr; 2018; 42(1):155-161. PubMed ID: 28806321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.
    Young K; Fidelman N; Yao FY; Hills NK; Kohi MP; Kolli KP; Taylor AG; Kerlan RK
    Liver Transpl; 2015 Apr; 21(4):454-67. PubMed ID: 25678220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
    Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.
    Ladd LM; Tirkes T; Tann M; Agarwal DM; Johnson MS; Tahir B; Sandrasegaran K
    Clin Mol Hepatol; 2016 Dec; 22(4):450-457. PubMed ID: 27987537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
    Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
    J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Imaging Reporting and Data System:: Substantial Discordance Between CT and MR for Imaging Classification of Hepatic Nodules.
    Zhang YD; Zhu FP; Xu X; Wang Q; Wu CJ; Liu XS; Shi HB
    Acad Radiol; 2016 Mar; 23(3):344-52. PubMed ID: 26777590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted MRI as a screening tool for hepatocellular carcinoma in cirrhotic livers: correlation with explant data-a pilot study.
    McNamara MM; Thomas JV; Alexander LF; Little MD; Bolus DN; Li YE; Morgan DE
    Abdom Radiol (NY); 2018 Oct; 43(10):2686-2692. PubMed ID: 29500648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of hypovascular lesions on dynamic computed tomography and/or gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Gyoda Y; Imamura H; Ichida H; Yoshimoto J; Ishizaki Y; Kuwatsuru R; Kawasaki S
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1242-1248. PubMed ID: 30345571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
    Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
    Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm.
    Choi MH; Choi JI; Lee YJ; Park MY; Rha SE; Lall C
    AJR Am J Roentgenol; 2017 Mar; 208(3):544-551. PubMed ID: 28026208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
    Teefey SA; Hildeboldt CC; Dehdashti F; Siegel BA; Peters MG; Heiken JP; Brown JJ; McFarland EG; Middleton WD; Balfe DM; Ritter JH
    Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.